Cimetidine
Sold as Secadine, Hexamet, Cymi, A-lennon cimetidine, Cimlok, Cimetidine adco, Aci-med, Norton- cimetidine, Norton cimetidine, Cimetidine arya, Garec-cimetidine, Lenamet otc, Ulcim, Bio-cimetidine, Pharma-q cimetidine, Mexiena, Tagamet, Tagamet iv, Lenamet, Dyspamet chewtab, Dyspamet, Lenamet 2oo mg/, Ulmet, Adco-cimetidine, Sandoz cimetidine
1-Cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
Drag to rotate. Structure from PubChem CID 2756.
Background
Registration
- Applicants
- 14
- Registrations
- 45
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Biotech Laboratories (Pty) Ltd | Secadine, Bio-cimetidine, Mexiena | 200 mg, 400 mg | 270102, 270103, 310679, 310680, 560740 | S3S2 to S3 by pack | PIPIL |
| Viatris South Africa (Pty) Ltd | Secadine | syrup | 270104 | Not determined | None |
| Sandoz South Africa (Pty) LtdCancelled | Hexamet | 400 | 270208 | Not determined | None |
| Pharmacare limited û woodmead15 of 17 cancelled | Cymi, A-lennon cimetidine, Lenamet otc, Ulcim, Tagamet, Tagamet iv, Lenamet, Dyspamet chewtab, Dyspamet, Lenamet 2oo mg/ | 200 mg, 400 mg, injection, 2 ml, 200 mg/5 ml, 800 mg | 280188, 280189, 300412, 300492, J0307, J0308, J0309, P0173, S0328, T0022, U0066, U0067, W0227, W0307, W0308, Y0032, Z0176 | Not determined | None |
| Pharma-q Holdings (Pty) Ltd | Cimlok, Pharma-q cimetidine | 200 mg, 200 mg/2 ml, 400 mg | 290193, 290194, 320196 | Not determined | None |
| Adcock Ingram Critical Care (Pty) Ltd | Cimetidine adco | 100 mg/ml | 290214 | Not determined | None |
| Triomed (Pty) Ltd | Aci-med | 400 mg | 290445 | Not determined | None |
| Medicine Developers International (Pty) Ltd | Norton- cimetidine, Norton cimetidine | 200, 400, 800 | 290677, 290678, 290679 | Not determined | None |
| Arya Pharma (Pty) Ltd1 of 3 cancelled | Cimetidine arya | 200, 400, 800 | 300046, 300047, 300059 | Not determined | None |
| Garec (Pty) LtdCancelled | Garec-cimetidine | 200, 400 mg, 800 | 300102, 300103, 300115 | Not determined | None |
| Merck Generics Rsa (Pty) Ltd | Ulmet | 200, 400 | Y0405, Y0406 | Not determined | None |
| Adcock ingram limited1 of 3 cancelled | Adco-cimetidine | 200 mg, 400 mg, 800 mg | Y0426, Y0427, Y0428 | Not determined | None |
| Quatromed limited | Ulcim | 400 mg | Z0177 | Not determined | None |
| Dezzo Trading 392 (Pty) Ltd | Sandoz cimetidine | 400 | Z0350 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Secadine tablets 200 MG EACH TABLET CONTAINS :CIMETIDINE 200 mg | 200 mgTablets | 27010227/11.4.3/0102 | Registered | Not determined | None |
| Secadine tablets 400 MG EACH TABLET CONTAINS :CIMETIDINE 400,0 mg | 400 mgTablets | 27010327/11.4.3/0103 | Registered | Not determined | None |
| Secadine syrup* EACH 5 ml SYRUP CONTAINS CIMETIDINE HYDROCHLORIDE EQUIVALENT TO CIMETIDINE 200 mg | Syrup | 27010427/11.4.3/0104 | Registered | Not determined | None |
| Hexamet 400 EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 | 27020827/11.4.3/0208 | Cancelled | Not determined | None |
| Cymi - 200 EACH TABLET CONTAINS CIMETIDINE 200 MG | - 200 | 28018828/11.4.3/0188 | Cancelled | Not determined | None |
| A-lennon cimetidine 400 MG tablets EACH TABLET CONTAINS CIMETIDINE 400 MG | 400 mgTablets | 28018928/11.4.3/0189 | Cancelled | Not determined | None |
| Cimlok 200 MG EACH TABLET CONTAINS CIMETIDINE 200 MG | 200 mg | 29019329/11.4.3/0193 | Registered | Not determined | None |
| Cimlok 400 MG EACH TABLET CONTAINS CIMETIDINE 400,0 mg | 400 mg | 29019429/11.4.3/0194 | Registered | Not determined | None |
| Cimetidine adco 100 mg/ml EACH 2 ml SOLUTION CONTAINS CIMETIDINE 200 mg | 100 mg/ml | 29021429/11.4.3/0214 | Registered | Not determined | None |
| Aci-med 400 MG tablets EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mgTablets | 29044529/11.4.3/0445 | Registered | Not determined | None |
| Norton- cimetidine 200 EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | 29067729/11.4.3/0677 | Registered | Not determined | None |
| Norton cimetidine 400 EACH TABLET CONTAINS CIMETIDINE 400 MG | 400 | 29067829/11.4.3/0678 | Registered | Not determined | None |
| Norton cimetidine 800 EACH TABLET CONTAINS CIMETIDINE 800 mg | 800 | 29067929/11.4.3/0679 | Registered | Not determined | None |
| Cimetidine 200 arya EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | 30004630/11.4.3/0046 | Registered | Not determined | None |
| Cimetidine 400 arya EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 | 30004730/11.4.3/0047 | Registered | Not determined | None |
| Cimetidine 800 arya TABLET CIMETIDINE 800 MG | 800 | 30005930/11.4.3/0059 | Cancelled | Not determined | None |
| Garec-cimetidine 200 EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | 30010230/11.4.3/0102 | Cancelled | Not determined | None |
| Garec-cimetidine 400 MG EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mg | 30010330/11.4.3/0103 | Cancelled | Not determined | None |
| Garec-cimetidine 800 EACH TABLET CONTAINS CIMETIDINE 800 mg | 800 | 30011530/11.4.3/0115 | Cancelled | Not determined | None |
| Lenamet otc EACH TABLET CONTAINS CIMETIDINE 200 mg | Not listed | 30041230/11.4.3/0412 | Registered | Not determined | None |
| Ulcim injection EACH 2 ml SOLUTION CONTAINS CIMETIDINE 200 mg | Injection | 30049230/11.4.3/0492 | Cancelled | Not determined | None |
| Bio-cimetidine 200 EACH TABLET CONTAINS CIMETIDINE 200,0 mg | 200Film-coated tablets | 31067931/11.4.3/0679Approved 28 March 2024 | Registered | S3 | PIPIL |
| Bio-cimetidine 400 EACH TABLET CONTAINS CIMETIDINE 400,0 mg | 400Film-coated tablets | 31068031/11.4.3/0680Approved 28 March 2024 | Registered | S3 | PIPIL |
| Pharma-q cimetidine injection 200 mg/2 ML EACH 2,0 ml AMPOULE CONTAINS CIMETIDINE 200,0 mg | 200 mg/2 mlInjection | 32019632/11.4.3/0196 | Registered | Not determined | None |
| Mexiena EACH TABLET CONTAINS CIMETIDINE 200,0 mg | 200 mgFilm-coated tablets | 56074056/11.4.3/0740Approved 20 August 2024 | Registered | S2 | PIPIL |
| Tagamet 200 EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | J0307J/11.4.3/307 | Cancelled | Not determined | None |
| Tagamet syrup 200 mg/5 ML EACH 5 mL SYRUP CONTAINS CIMETIDINE HYDROCHLORIDE EQUIVALENT TO CIMETIDINE 200 mg | 200 mg/5 mlSyrup | J0308J/11.4.3/308 | Cancelled | Not determined | None |
| Tagamet ampoules 200 MG EACH 2 ml SOLUTION CONTAINS CIMETIDINE 200 mg | 200 mgAmpoules | J0309J/11.4.3/309 | Cancelled | Not determined | None |
| Tagamet tablets 400 MG EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mgTablets | P0173P/11.4.3/173 | Cancelled | Not determined | None |
| Tagamet iv 400 EACH 100,0 ml SOLUTION CONTAINS CIMETIDINE 400,0mg | 400 | S0328S/11.4.3/328 | Cancelled | Not determined | None |
| Tagamet tablets 800 MG EACH TABLET CONTAINS CIMETIDINE 800,0 mg | 800 mgTablets | T0022T/11.4.3/22 | Cancelled | Not determined | None |
| Lenamet 200 EACH TABLET CONTAINS CIMETIDINE 200 MG | 200 | U0066U/11.4.3/66 | Cancelled | Not determined | None |
| Lenamet-400 EACH TABLET CONTAINS CIMETIDINE 400 MG | 400 | U0067U/11.4.3/67 | Cancelled | Not determined | None |
| Lenamet - 800 EACH TABLET CONTAINS CIMETIDINE 800 mg | - 800 | W0227W/11.4.3/227 | Cancelled | Not determined | None |
| Dyspamet chewtab tablets 200 MG EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 mgTablets | W0307W/11.4.3/307 | Cancelled | Not determined | None |
| Dyspamet suspension 200 mg/5 ML EACH 5 ml SUSPENSION CONTAINS CIMETIDINE 200 mg | 200 mg/5 mlSuspension | W0308W/11.4.3/308 | Cancelled | Not determined | None |
| Lenamet injection 2oo mg/2 ML EACH 2 ml AMPOULE CONTAINS CIMETIDINE 200 mg | 2 mlInjection | Y0032Y/11.4.3/32 | Registered | Not determined | None |
| Ulmet 200 EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | Y0405Y/11.4.3/405 | Registered | Not determined | None |
| Ulmet 400 * EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 | Y0406Y/11.4.3/406 | Registered | Not determined | None |
| Adco-cimetidine 200 MG EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 mg | Y0426Y/11.4.3/426 | Registered | Not determined | None |
| Adco-cimetidine 400 MG EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mg | Y0427Y/11.4.3/427 | Registered | Not determined | None |
| Adco-cimetidine 800 MG EACH TABLET CONTAINS CIMETIDINE 800 MG | 800 mg | Y0428Y/11.4.3/428 | Cancelled | Not determined | None |
| Ulcim 200 MG EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 mg | Z0176Z/11.4.3/176 | Cancelled | Not determined | None |
| Ulcim 400 MG EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mg | Z0177Z/11.4.3/177 | Registered | Not determined | None |
| Sandoz cimetidine 400 EACH TABLET CONTAINS CIMETIDINE 400,0 mg | 400 | Z0350Z/11.4.3/350 | Registered | Not determined | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cimetidine
S3: Cimetidine
- except when intended for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity, subject to a maximum unit dose of 200 milligrams, a maximum daily dose (per 24 hours) of 800 milligrams and a maximum treatment period of 2 weeks. (S2)
Consolidated Schedules 06 July 2026, lines 3332 to 3334
S2: Cimetidine
- when intended for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity, subject to a maximum unit dose of 200 milligrams, a maximum daily dose of 800 milligrams and a maximum treatment period of 2 weeks. (S3)
Consolidated Schedules 06 July 2026, lines 1740 to 1742
Pharmacological class: Other. (class 11.4.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Bio-cimetidine 200, Biotech Laboratories (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.